Purpose:
The aim of this study was to investigate factors predictive of subretinal fluid (SRF) resolution in Coats disease.
Design:
Retrospective cohort study.
Methods:
Institutional review board-approved review of patients diagnosed with Coats disease demonstrating SRF (stage 3–5) at a single center from November 1973 to July 2018 with comparison of eyes that had resolution of SRF to those in which SRF persisted.
Results:
There were 177 cases (154 males, 87%) of Coats disease diagnosed at a mean age of 8 years. After a mean follow-up of 62 months, SRF resolved in 110 (62%) and persisted in 67 (38%) eyes. Comparison (resolved SRF vs persistent SRF) revealed classification as stage 3A [63 (57%) vs 20 (29%)], stage 3B [47 (43%) vs 40 (60%)], or stage 4 [0 (0%) vs 7 (11%)] (
P
< 0.001). Eyes with resolved SRF presented with fewer clock hours of telangiectasia (mean: 5 vs 7 clock hours,
P
< 0.001), light bulb aneurysms (mean: 5 vs 7 clock hours,
P
< 0.001), exudation (mean: 7 vs 10 clock hours,
P
< 0.001), and extent of SRF (mean: 7 vs 10 clock hours,
P
< 0.001). Factors predictive of SRF resolution included absence of iris neovascularization on fluorescein angiography [odds ratio 0.05 (95% confidence interval 0.01–0.60),
P
= 0.02], and less elevated SRF by ultrasonography [odds ratio 0.84 (95% confidence interval 0.76–0.95),
P
= 0.004). For every 1-mm decrease in SRF, likelihood of SRF resolution increased by 16%.
Conclusions:
Resolution of SRF was achieved in the majority of eyes (62%) with stage 3 to 5 Coats disease. Predictors of SRF resolution included lack of neovascularization on fluorescein angiography and less elevation of SRF by ultrasonography.